ImmunoGen (IMGN) ROE US GAAP (year values) |
||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | |||
| ROE, % | ? | -1 406% | 160.4% | -74.4% | -42.8% | -143.1% | -13.0% | |
| Changes by years, y/y, % | -1 942pp | +1 566pp | -235pp | +32pp | -100pp | |||
ImmunoGen. ROE, %
ImmunoGen. ROE, changes, pp
ImmunoGen (IMGN) ROE US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| ROE, % | ? | -114.4% | -144.7% | -197.4% | -37.1% | -13.0% | -13.0% | |
| Changes by years, y/y, % | -23pp | -102pp | -155pp | +28pp | +101pp | |||
| Changes by quarters, q/q, % | -49pp | -30pp | -53pp | +160pp | +24pp | |||